Zarontin 250 mg
The same active substance, strength and form as listed by each country’s medicines regulator. For showing a pharmacist abroad.
- Active substance
- Ethosuximide
- Strength
- 250 mg
- Form
- Capsule
- ATC code
- Not stated by the register
- Registered in
- United States · Parke-Davis Div of Pfizer Inc
- Prescription
- Prescription only
- NDC
- 0071-0237
Source: NDC Directory · 2026-09-13
Not a prescription. Not a statement that these products are interchangeable. Products are matched on active substance, strength and kind of form only. Other ingredients, release, approved uses and the dose on the box can differ. A pharmacist or doctor decides whether one can replace another.
Listed in other countries
Bulgaria 1 matching products
| Name on the box | Strength and form | Prescription | Holder | Official record |
|---|---|---|---|---|
| PetinimidПетинимид | 250 mg capsules, soft · capsule | Prescription only | G.L. Pharma GmbH | 20110261 |
Source: Bulgarian Drug Agency register (Изпълнителна агенция по лекарствата (BDA)) · 2026-08-01
Canada 3 matching products
| Name on the box | Strength and form | Prescription | Holder | Official record |
|---|---|---|---|---|
| MAR-ETHOSUXIMIDE | 250 mg · capsule | Prescription only | Marcan Pharmaceuticals Inc | 02545772 |
| ODAN-ETHOSUXIMIDE | 250 mg · capsule | Prescription only | Odan Laboratoriesltd | 02547171 |
| ZARONTIN | 250 mg · capsule | Prescription only | Searchlight Pharma Inc | 00022799 |
Source: Drug Product Database (Health Canada) · 2026-09-30 · Contains information licensed under the Open Government Licence – Canada.
Netherlands 2 matching products
| Name on the box | Strength and form | Prescription | Holder | Official record |
|---|---|---|---|---|
| Ethosuximide Strides 250 mg zachte capsules | 250 mg · capsule, zacht | Prescription only | Strides Pharma (Cyprus) Limited | 123574 |
| Ethymal 250 mg | 250 mg · capsule, zacht | Prescription only | Aurobindo Pharma B.V. | 02982 |
Source: Geneesmiddeleninformatiebank (College ter Beoordeling van Geneesmiddelen (CBG-MEB)) · 2026-09-30 · Bron: College ter Beoordeling van Geneesmiddelen (CBG). De Rijksoverheid is het niet automatisch eens met de inhoud van deze site.